Stephen Mahoney
Vermogen: 587 609 $ op 31-05-2026
Vermogen: 587 609 $ op 31-05-2026
Stephen Frank Mahoney was the founder of Kiniksa Pharmaceuticals Ltd., founded in 2015, where the title held was President & Chief Operating Officer from 2017 to 2019.
Current jobs include President, Chief Executive Officer & Director at Viridian Therapeutics, Inc. since 2023, and Director at Vesselon, Inc. Former jobs include Attorney at Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC; Chief Commercial Officer & Senior Vice President at Synageva BioPharma Corp.
from 2014 to 2015; COO, CFO, Treasurer & Chief Accounting Officer at Magenta Therapeutics, Inc. from 2020 to 2023; Chief Operating & Financial Officer at Dianthus Therapeutics, Inc. from 2020 to 2023; and Attorney at Genzyme Corp.
Education includes undergraduate studies at The Colorado College, graduate studies at Boston College Law School, and an MBA from Wallace E Carroll School of Management.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 31-03-2026 | 33.349 ( 0,03% ) | 587 609 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| VIRIDIAN THERAPEUTICS, INC. | Algemeen Directeur | 30-10-2023 |
Vesselon, Inc.
Vesselon, Inc. Medical SpecialtiesHealth Technology Develops a portable ultrasound device for brain stroke treatment | Directeur/Bestuurslid | - |
| Bedrijven | Functie | Einde |
|---|---|---|
| DIANTHUS THERAPEUTICS, INC. | Financieel Directeur/CFO | 01-09-2023 |
Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Oprichter | 15-11-2019 |
| SYNAGEVA BIOPHARMA CORP | Corporate Officer/Principal | 01-01-2015 |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | - |
| MAGENTA THERAPEUTICS | Financieel Directeur/CFO | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 11 |
|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Vesselon, Inc.
Vesselon, Inc. Medical SpecialtiesHealth Technology Develops a portable ultrasound device for brain stroke treatment | Health Technology |
Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC
Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
The Colorado College
The Colorado College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Synageva BioPharma Corp.
Synageva BioPharma Corp. BiotechnologyHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
Boston College Law School
Boston College Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wallace E Carroll School of Management
Wallace E Carroll School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Health Technology |
Magenta Therapeutics, Inc.
Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines | Health Technology |
Viridian Therapeutics, Inc.
Viridian Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and manufactures monoclonal antibody products | Health Technology |
Dianthus Therapeutics, Inc.
Dianthus Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for patients with autoimmune and inflammatory diseases | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau